Additionally, both mRNA and protein levels of FBXL7 were found to be reduced in pancreatic cancer tissues, compared to those in the corresponding tumor-adjacent normal tissues [23]. This evidence concerns the gene FBXL7 and familial pancreatic carcinoma.